Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 856

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 856
---
 Region as may be applicable, and to obtaining all necessary approvals required by the applicable agencies of the governments within the United States and any other relevant countries. WuXi Biologics and Aadi shall cooperate with each other
and shall provide assistance to the other as reasonably necessary to obtain any required approvals.

16.12 Counterparts; Other Matters. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Signatures to this Agreement delivered by facsimile
or in another electronic form (e.g., via PDF or DocuSign) will be deemed to be binding as originals. This Agreement is established in the English language. Any translation in another language shall be deemed for convenience only and shall never
prevail over the original English version.

[Remainder of this page intentionally blank.]

G-32

IN WITNESS WHEREOF, the Parties have executed this Exclusive License Agreement as of the date first set forth above.

| WUXI BIOLOGICS (SHANGHAI FX) CO., LTD. |
| BY:                                    |
| NAME:  Zhisheng Chen                   |
| TITLE:  Chief Executive Officer        |

| AADI BIOSCIENCE, INC.                       |
| BY:                                         |
| NAME:  David J. Lennon, Ph.D.               |
| TITLE:  President & Chief Executive Officer |

SCHEDULE 1.17

[***]

SCHEDULE 1.40

[***]

SCHEDULE 1.43

LICENSED PLATFORM PATENTS

[***]

SCHEDULE 1.59

PRE-CLINICALCANDIDATE CRITERIA

[***]

SCHEDULE 1.75

UPSTREAM AGREEMENTS

[***]

SCHEDULE 2.3(a)

INITIAL TRANSFER OF KNOW-HOWAFTER THE EFFECTIVE DATE

[***]

SCHEDULE 9.6

PRESS RELEASE

Annex H AADI BIOSCIENCE, INC. 2021 EQUITY INCENTIVE PLAN (as amended and restated [ ], 2025 (the “ Restatement Date”)) 1. Purposes of the Plan. The purposes of this Plan are:

| • |     | to attract and retain the best available personnel for positions of substantial responsibility, |

| • |     | to provide additional incentive to Employees, Directors and Consultants, and |

| • |     | to promote the